Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 03 Sept 2026 for Apogee Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleJane Henderson
Insider track record
Disclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jane Henderson: trading record in brief
Jane Henderson, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Apogee Therapeutics, Inc., Akero Therapeutics, Inc. and IVERIC bio, Inc. The record holds 23 filings, for trades running from 11 May 2022 to 3 September 2026.
No open-market purchase appears, only 14 sales worth €1.5M. Outside the open market, there are 1 share grant and 4 option exercises. In 2026 alone, the filings show no purchases and 7 sales.
On 3 September 2026 came the latest disclosure, a transaction in Apogee Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jane Henderson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
158,371 sharesCommon StockSEC:0001140361-26-035611:0
15,000 shares0Common StockSEC:0001104659-26-086729:0
2,000 shares@ US$90.000.0017% mcap29.6% of flowCommon StockSEC:0001104659-26-045062:0
900 shares@ US$84.469.9% of flowCommon StockSEC:0001104659-26-039708:0
1,100 shares@ US$85.4612.2% of flowCommon StockSEC:0001104659-26-039708:1
2,000 shares@ US$85.0018.1% of flowCommon StockSEC:0001104659-26-036332:0
300 shares@ US$68.271.3% of flowCommon StockSEC:0001104659-26-023651:0
792 shares@ US$65.213.2% of flowCommon StockSEC:0001104659-26-010453:0
1,920 shares@ US$74.139.0% of flowCommon StockSEC:0001104659-26-001483:0
1,500 shares@ US$80.0028.2% of flowCommon StockSEC:0001104659-25-124354:0
9,398 sharesCommon StockSEC:0001193125-25-312098:0
1,500 shares@ US$75.008.3% of flowCommon StockSEC:0001104659-25-118985:0
1,500 shares@ US$70.008.6% of flowCommon StockSEC:0001104659-25-117036:0
2,000 shares@ US$65.0011.5% of flowCommon StockSEC:0001104659-25-112825:0
1,000 shares@ US$60.006.0% of flowCommon StockSEC:0001104659-25-111631:0
3,000 shares@ US$7.0094.5% of flowCommon StockSEC:0000950170-25-107545:0
3,000 shares@ US$47.45730.8% of flowCommon StockSEC:0000950170-25-107545:1
9,398 shares0Common StockSEC:0000950170-25-082311:0
6,000 shares@ US$48.2671.8% of flowCommon StockSEC:0001104659-24-092519:0
22,088 sharesCommon StockSEC:0001104659-23-080683:0
40,000 shares@ US$7.0164.7% of flowCommon StockSEC:0000950170-23-029228:0
14,588 sharesCommon StockSEC:0001410939-23-000073:0
7,500 sharesCommon StockSEC:0001410939-22-000070:0
23 of 23 declarations
